so will publish for others this information in the hope that it will help some
Remember always keep on top of your health
Breakthrough Prostate Cancer Treatments
Dear Health Alert Reader,
Your health and the health of your loved ones is the foremost priority of the Johns Hopkins Prostate Bulletin editorial advisory board. If you, or someone you love, has prostate disease you need the most current, reliable information you can get so you can make the best informed decisions about your future.That's why we've taken the liberty of reserving five FREE Prostate Health reports in your name:
· FREE Special Report #1: BPH: Reviewing the Options.
A must-read report on treatment options for benign prostate enlargement, with an emphasis on minimally-invasive techniques for treatment of this common disorder in men.
· FREE Special Report #2: Diet and Prostate Health.
Researchers now think up to 90% of all prostate cancers have dietary links. Our Special Report includes specific nutritional guidelines for preventing -- and coping with -- prostate disorders.
· FREE Special Report #3: Treating Overactive Bladder.
An in-depth look at current options for treating OAB -- including a close-up look at a new generation of medications that have fewer side effects than more commonly prescribed drugs.
· FREE Special Report #4: Chronic Prostatitis: New Research, Renewed Hope.
If you're one of the millions of American men who suffer from this frustrating condition, don't despair. Breakthrough research studies are pointing the way to important new therapies you need to know about.
· FREE Special Report #5: The Radical Prostatectomy.
One of the most authoritative reports on the subject available, written by Jacek L. Mostwin, M.D., D. Phil. (Oxon), Professor of Urology at Johns Hopkins, is head of the Division of Reconstructive and Neurological Urology. Essential reading for anyone facing the prospect of surgery or its after effects.
All five are yours to keep with our compliments, as your introduction to one of the most valuable health resources you'll ever benefit from:
The Johns Hopkins Prostate Bulletin is the most comprehensive up-to-the-minute round-up of prostate care advances, new research findings, and clinical trials ever made available to medical consumers.
The Johns Hopkins Prostate Bulletin works with doctors and professors of urology at one of the nation's foremost urological center, we are constantly impressed by the wealth of new therapies, important breakthroughs and newly-discovered preventive measures available to men at high risk for prostate problems, or undergoing treatment for them.
Yet for the average medical consumer, the information has simply been inaccessible -- hidden in obscure medical journals or buried in miniscule articles in the back of the daily newspaper. Even many physicians may not have ready access to up-to-the-minute research in this highly specialized field.
As the nation's leading center for prostate care and research, Johns Hopkins' James Buchanan Brady Urological Institute is in a unique position to evaluate and disseminate the very latest information concerning advances in prostate treatment. Now, Dr. Jacek Mostwin is leading a team of world-class prostate specialists as chief medical editor of a remarkable publication created for that precise purpose.
The Johns Hopkins Prostate Bulletin has one simple mission, one clear focus: to provide those facing prostate health challenges with the kind of authoritative, leading-edge information they need to take charge of their medical care -- intelligently and effectively.
The Johns Hopkins Prostate Bulletin brings you eye-opening reports about new therapeutic avenues. . . advance news of clinical trials in which you can participate. . . detailed answers to subscribers' most pressing questions and concerns. . . revealing research findings about nutrition, supplementation, lifestyle influences and diagnostic tools. . . and the latest news from urological and cancer conferences around the world. All with a single relentless focus on prostate issues and the preservation of your health and quality of life, and without mysterious medical jargon -- so you can clearly understand what the advances mean to you.
This can literally be life-changing information -- especially if you fall within the prostate high-risk target zone, which includes men over 40, African-Americans, and any male with a family history of prostate problems. In recent issues, The Prostate Bulletin subscribers have learned about:
· Exciting lab tests of a powerful molecule, developed by a researcher at Yale, that appears to attack prostate cancer cells in mice and wipe them out. Human clinical trials are expected to be underway shortly. The Prostate Bulletin will provide contacts for these trials as soon as they are announced.
· Why experts now estimate that up to 90 percent of cancers of the prostate may have a dietary link.
· New evidence that the progression of prostate cancer may actually be slowed by dietary changes. One study published in the Journal of Urology found that tumor cells from men taking flaxseed in combination with a lowfat diet appeared to be growing more slowly and dying more quickly than those of the control group.
· Two types of foods that should be included plentifully in the diet of anyone at risk for prostate problems -- or experiencing them.
· Expert guidance for dealing with erectile dysfunction and restoring intimacy and sexual satisfaction after prostate surgery.
· Important prostate issues to consider if you're contemplating testosterone replacement therapy. The good news: most urologists now recommend replacement therapy for men with low testosterone levels -- provided careful follow-up examinations are maintained.
· Must-read comparison of the new laparoscopic prostatectomy with the traditional radical prostatectomy. The latest reports from the annual meeting of the American Urological Association offer important insights about the relative merits of both approaches for curing prostate cancer and maintaining quality of life.
· Why a new use of an oral hormonal medication may represent an important breakthrough in prostate cancer treatment.
· How a team of scientists and physicians is zeroing in on an improved Prostate Specific Antigen (PSA) test -- one which will reduce false positive readings and provide greater accuracy in predicting which men have PSA elevations due to benign prostate enlargement, and which are due to prostate cancer. The Prostate Bulletin readers will be kept apprised of their success as the data is reported.
· Five questions you should ask your surgeon if you are facing a radical prostatectomy. If he answers negatively to any one of them consider seeking treatment elsewhere. Question #1: does he know and use the nerve-sparing techniques in performing prostate surgery?
· Overactive bladder? You're not alone -- an estimated 17 million Americans, most under the age of 65, are affected by OAB. Your symptoms could be caused by one of the 12 trigger foods we reported on in our latest in-depth report on treating overactive bladder.
· The biggest mistake physicians make in prescribing drugs for prostate enlargement. Important reading for anyone taking Hytrin, Cardura, Flomax or Minipress.
· The pros and cons of medications, minimally-invasive therapies, and surgical alternatives in treating benign prostatic hyperplasia (BPH) -- the most common benign tumor found in men. Dr. Alan W. Partin, M.D., Ph.D, and Distinguished Professor of Urologic Oncology at the Johns Hopkins University School of Medicine reviews treatment options in our in-depth report on BPH.
· Where to find national listings of clinical trials of new therapies for BPH and prostate cancer -- and how you can apply to take part in them.
The most important publication you'll ever read --
yet your subscription is entirely risk-FREE.
If you or a loved one has reason to be concerned about prostate health, The Johns Hopkins Prostate Bulletin is the most essential resource you'll ever subscribe to -- even if you've never been diagnosed with a health-threatening prostate condition. The Prostate Bulletin will keep you abreast of the latest studies, therapies, and breakthroughs, alert you to clinical trials in which you can participate, and bring you the latest news from urological and cancer conferences around the world. All without medical jargon -- so you can clearly understand what the advances mean to you.
This can literally be life-saving information. . . yet your subscription to The Prostate Bulletin is entirely risk-FREE. The subscription cost is just $149 for four quarterly issues. . . a savings of $46 off the regular subscription price. And, here's more good news: If you are dissatisfied with the Bulletin at any time, for any reason. . . simply contact us for a prompt and complete refund, no questions asked.
The five FREE Prostate Bulletin Special Reports
are yours to keep, even if you decide not to continue.
Recently, we issued five Special Reports on prostate health issues that we consider so important, we want you to have them immediately. All five will be included on a complimentary basis with your subscription -- and they're yours to keep even if you don't continue as a subscriber to the Prostate Bulletin. You'll receive Special Reports on:
· FREE Special Report #1: BPH: Reviewing the Options.
A must-read report on treatment options for benign prostate enlargement. From watchful waiting and pharmaceutical therapies, to surgical solutions, this comprehensive guide explains the alternatives and lists the pros and cons of each.
· FREE Special Report #2: Diet and Prostate Health.
Researchers now think up to 90% of all prostate cancers have dietary links. Our Special Report includes the latest dietary guidelines for preventing cancer, and possibly even slowing its growth.
· FREE Special Report #3: Treating Overactive Bladder.
An in-depth look at the complete range of current options for treating OAB -- including some your physician may not yet be familiar with.
· FREE Special Report #4: Chronic Prostatitis: New Research, Renewed Hope.
If you're one of the millions of American men who suffer from this frustrating condition, don't despair. Breakthrough research studies are pointing the way to promising new therapeutic avenues.
· FREE Special Report #5: The Radical Prostatectomy.
If you're facing prostate surgery or recovering from it, this Special Report by a leading authority in the field is must reading.
A risk-FREE opportunity
to improve your medical outlook --
and save $46!
All five Special Reports are yours to keep without risk, obligation or further commitment as a gift of good health from your friends at Johns Hopkins. We know these Special Reports will make a major difference in your prostate health outlook. But we also know that they only scratch the surface of the wealth of vital information available to you as a subscriber to The Prostate Bulletin.
Your subscription will include:
· Four quarterly issues of The Prostate Bulletin, packed with up-to-the-minute health-essential information.
· Personal Letter reviewing critical prostate developments of the past few weeks. Each issue of The Prostate Bulletin starts with Dr. Mostwin's Personal Letter -- up to 20 pages of late-breaking news and information about the very latest treatment strategies and early intervention options, plus first-hand reports from urological conferences around the world that are helping men to prolong their lives, and improve their quality of life.
· In-Depth Reports on prostate health issues ranging from treatment options and preventive measures to prostatectomy techniques and new diagnostic tools. Each report is authored by a recognized expert on its topic -- including such medical authorities as Dr. H. Logan Holtgrewe, M.D., former president of the American Urological Association. . . Dr. Alan W. Partin, M.D., Ph.D., Urologist-in-Chief of the James Buchanan Brady Urological Institute and editor-in-chief of Urology. . . Dr. Patrick C. Walsh, M.D., former Director of the James Buchanan Brady Urological Institute. . . and literally dozens more who are at the forefront of prostate research and treatment.
· Participation in our Grand Rounds forum -- in which readers have the opportunity to pose specific prostate health questions to Johns Hopkins specialists. While we can't guarantee that every single question will be answered, typical issues include as many as ten to twelve pages' worth of readers' questions and expert answers.
· 5 FREE Special Reports on important prostate issues, yours to keep even if you decide not to continue with your subscription.
When it comes to prostate care, information is the best medicine.
To order your Risk-Free copy of the Prostate Bulletin. . . and get your 5 FREE Special Reports. . . just click below now:
